Keryx Biopharma (KERX) Posts In-Line Q3 Loss of 10c
Tweet Send to a FriendGet Alerts KERX Hot Sheet
Price: $8.24 +7.57%
EPS Growth %: +76.9%
Financial Fact:
Interest and other income, net: 103K
Today's EPS Names:
CEDU, CHC, CIDM, More
EPS Growth %: +76.9%
Financial Fact:
Interest and other income, net: 103K
Today's EPS Names:
CEDU, CHC, CIDM, More
Trade KERX Now!
Keryx Biopharmaceuticals Inc. (Nasdaq: KERX) reports Q3 loss of $0.10, versus the consensus of ($0.10).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
- Crown Crafts, Inc. (CRWS) Posts Flat Q4 EPS of 19c
- John Wiley (JW-A) Misses Q4 EPS by 9c; Names New CFO; Updates on Restructuring
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
